$XOMA Recent News SP 500 stages ‘the expectedâ
Post# of 102867
Posted On: 03/05/2014 9:48:58 AM
$XOMA Recent News
S&P 500 stages ‘the expected’ break to all-time highs 12:04 p.m. Feb. 28, 2014 - Michael Ashbaugh
Restoration Hardware shares fall on co-CEO resigning 6:07 p.m. Dec. 12, 2013 - Wallace Witkowski
3 new bets by a biotech hedge fund 3:56 a.m. July 10, 2012 - The Trading Deck
XOMA wins US rights to market blood pressure drugs 5:56 p.m. Jan. 17, 2012 - MarketWatch.com
XOMA off 20% premarket on downgrade 34 min ago - Seeking Alpha
UPDATE: XOMA Offers Update on Gevokizumaba, Says Results Do Not Support Movement to Pivotal Development Trial 3:42 p.m. March 4, 2014 - benzinga.com
Orphan Drug Status for XOMA's Gevokizumab - Analyst Blog 5:40 p.m. Feb. 25, 2014 - Zacks.com
Orphan Drug Status for XOMA's Gevokizumab - Analyst Blog 5:40 p.m. Feb. 25, 2014 - Zacks.com
XOMA +4% as gevokizumab wins FDA orphan drug status 3:08 p.m. Feb. 25, 2014 - Seeking Alpha
First Week Of XOMA April 19th Options Trading 12:35 p.m. Feb. 25, 2014 - TheStreet.com
XOMA Corporation (XOMA) in Focus: Stock Moves 11.5% Higher - Tale of the Tape 8:37 a.m. Feb. 24, 2014 - Zacks.com
Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming 8:31 a.m. Feb. 11, 2014 - Seeking Alpha
Will Affymetrix (AFFX) Surprise This Earnings Season? - Analyst Blog 4:30 p.m. Jan. 29, 2014 - Zacks.com
Why XOMA Corporation (XOMA) Has A Bright Short-Term Future? - Tale of the Tape 8:40 a.m. Jan. 24, 2014 - Zacks.com
Interesting XOMA Put And Call Options For September 20th 12:13 p.m. Jan. 22, 2014 - TheStreet.com
Surging Earnings Estimates Signal Good News for XOMA Corporation (XOMA) - Tale of the Tape 8:52 a.m. Jan. 14, 2014 - Zacks.com
XOMA Corp (XOMA) Shares March Higher, Can It Continue? - Tale of the Tape 7:28 a.m. Jan. 13, 2014 - Zacks.com
Cramer's Lightning Round - I Can't Get My Arms Around The New Kodak (1/10/14) 6:29 a.m. Jan. 12, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I Don't Like Amgen 6:00 a.m. Jan. 11, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:20 p.m. Jan. 10, 2014 - TheStreet.com
Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire 8:33 a.m. Jan. 10, 2014 - 247WallSt.com
XOMA started a Buy at Jefferies 11:13 a.m. Jan. 9, 2014 - Seeking Alpha
Following Smart Money: Baker Brothers Investments In 2013 And Beyond, Part 2 8:01 a.m. Dec. 30, 2013 - Seeking Alpha
Short Interest In XOMA Drops 19.7% 11:31 a.m. Dec. 26, 2013 - TheStreet.com
XOMA Reports 2013 Operational Highlights and Fourth Quarter and Full-Year 2013 Financial Results 4:58 p.m. March 4, 2014 - GlobeNewswire
XOMA Provides Update on Gevokizumab Proof-of-Concept Program 4:37 p.m. March 4, 2014 - GlobeNewswire
XOMA Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum 6:21 p.m. Feb. 24, 2014 - GlobeNewswire
XOMA to Present at Upcoming Investor Conferences 6:25 p.m. Feb. 20, 2014 - GlobeNewswire
Stock Price Movements, and Invitations to Investors Conferences - Research Report on Valeant, XOMA, Gentium, Magellan, and Abiomed 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Stock Price Movements, New Drug Applications, and Public Offerings - Research Report on Impax, Volcano, Spectrum, XOMA, and Insulet 8:00 a.m. Dec. 25, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 8:12 a.m. Dec. 19, 2013 - PR Newswire
XOMA Announces Closing of the Offering and Exercise of Option 4:02 p.m. Dec. 18, 2013 - GlobeNewswire
Public Offerings, Merger Agreements, New Preclinical Data, New Treatments and Dividend Payments - Research Report on XOMA, MAKO, Alnylam, Avanir, and PDL BioPharma 8:00 a.m. Dec. 18, 2013 - PR Newswire
Opening Buzz: Adobe Systems Incorporated, Restoration Hardware Holdings, XOMA Corp, Bed Bath & Beyond 9:16 a.m. Dec. 13, 2013 - ACCESSWIRE
XOMA Announces Pricing of Approximately $50.0 Million Offering of Common Stock 9:14 a.m. Dec. 13, 2013 - GlobeNewswire
XOMA Announces Proposed Public Offering of Common Stock 4:05 p.m. Dec. 12, 2013 - GlobeNewswire
Divestitures, Event Participations, Patents, Clinical Studies and Trials - Research Report on Allergan, Zoetis, XOMA, Isis, and Arrowhead 8:00 a.m. Dec. 5, 2013 - PR Newswire
Bullish Trend Analysis Report: Petroleo Brasileiro Petrobras, XOMA Corp, Groupon Inc, EnteroMedics Inc, Schlumberger Limited 8:45 a.m. Dec. 4, 2013 - PR Newswire
Bullish Trend Analysis: Tesla Motors Inc, XOMA Corp, Keryx Biopharmaceuticals, Oncomed Pharmaceuticals 9:01 a.m. Dec. 3, 2013 - ACCESSWIRE
XOMA to Present at the Piper Jaffray Healthcare Conference 1:00 p.m. Nov. 26, 2013 - GlobeNewswire
Under AAAResearchReports.com Microscope: Celldex Therapeutics Inc., XOMA Corp., Illumina Inc., and Immunomedics Inc. 9:30 a.m. Nov. 25, 2013 - PR Newswire
XOMA Awarded Key Flexible Manufacturing Patent 9:00 a.m. Nov. 20, 2013 - GlobeNewswire
Healthcare Sector Announced Financial Results and Recognition - Research Report on Alnylam Pharmaceuticals, Opko, Enzymotec, Cambrex, and XOMA 8:00 a.m. Nov. 15, 2013 - PR Newswire
XOMA Highlights Recent Achievements and Reports Financial Results for Third Quarter 2013 4:02 p.m. Nov. 7, 2013 - GlobeNewswire
S&P 500 stages ‘the expected’ break to all-time highs 12:04 p.m. Feb. 28, 2014 - Michael Ashbaugh
Restoration Hardware shares fall on co-CEO resigning 6:07 p.m. Dec. 12, 2013 - Wallace Witkowski
3 new bets by a biotech hedge fund 3:56 a.m. July 10, 2012 - The Trading Deck
XOMA wins US rights to market blood pressure drugs 5:56 p.m. Jan. 17, 2012 - MarketWatch.com
XOMA off 20% premarket on downgrade 34 min ago - Seeking Alpha
UPDATE: XOMA Offers Update on Gevokizumaba, Says Results Do Not Support Movement to Pivotal Development Trial 3:42 p.m. March 4, 2014 - benzinga.com
Orphan Drug Status for XOMA's Gevokizumab - Analyst Blog 5:40 p.m. Feb. 25, 2014 - Zacks.com
Orphan Drug Status for XOMA's Gevokizumab - Analyst Blog 5:40 p.m. Feb. 25, 2014 - Zacks.com
XOMA +4% as gevokizumab wins FDA orphan drug status 3:08 p.m. Feb. 25, 2014 - Seeking Alpha
First Week Of XOMA April 19th Options Trading 12:35 p.m. Feb. 25, 2014 - TheStreet.com
XOMA Corporation (XOMA) in Focus: Stock Moves 11.5% Higher - Tale of the Tape 8:37 a.m. Feb. 24, 2014 - Zacks.com
Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming 8:31 a.m. Feb. 11, 2014 - Seeking Alpha
Will Affymetrix (AFFX) Surprise This Earnings Season? - Analyst Blog 4:30 p.m. Jan. 29, 2014 - Zacks.com
Why XOMA Corporation (XOMA) Has A Bright Short-Term Future? - Tale of the Tape 8:40 a.m. Jan. 24, 2014 - Zacks.com
Interesting XOMA Put And Call Options For September 20th 12:13 p.m. Jan. 22, 2014 - TheStreet.com
Surging Earnings Estimates Signal Good News for XOMA Corporation (XOMA) - Tale of the Tape 8:52 a.m. Jan. 14, 2014 - Zacks.com
XOMA Corp (XOMA) Shares March Higher, Can It Continue? - Tale of the Tape 7:28 a.m. Jan. 13, 2014 - Zacks.com
Cramer's Lightning Round - I Can't Get My Arms Around The New Kodak (1/10/14) 6:29 a.m. Jan. 12, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I Don't Like Amgen 6:00 a.m. Jan. 11, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:20 p.m. Jan. 10, 2014 - TheStreet.com
Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire 8:33 a.m. Jan. 10, 2014 - 247WallSt.com
XOMA started a Buy at Jefferies 11:13 a.m. Jan. 9, 2014 - Seeking Alpha
Following Smart Money: Baker Brothers Investments In 2013 And Beyond, Part 2 8:01 a.m. Dec. 30, 2013 - Seeking Alpha
Short Interest In XOMA Drops 19.7% 11:31 a.m. Dec. 26, 2013 - TheStreet.com
XOMA Reports 2013 Operational Highlights and Fourth Quarter and Full-Year 2013 Financial Results 4:58 p.m. March 4, 2014 - GlobeNewswire
XOMA Provides Update on Gevokizumab Proof-of-Concept Program 4:37 p.m. March 4, 2014 - GlobeNewswire
XOMA Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum 6:21 p.m. Feb. 24, 2014 - GlobeNewswire
XOMA to Present at Upcoming Investor Conferences 6:25 p.m. Feb. 20, 2014 - GlobeNewswire
Stock Price Movements, and Invitations to Investors Conferences - Research Report on Valeant, XOMA, Gentium, Magellan, and Abiomed 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Stock Price Movements, New Drug Applications, and Public Offerings - Research Report on Impax, Volcano, Spectrum, XOMA, and Insulet 8:00 a.m. Dec. 25, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 8:12 a.m. Dec. 19, 2013 - PR Newswire
XOMA Announces Closing of the Offering and Exercise of Option 4:02 p.m. Dec. 18, 2013 - GlobeNewswire
Public Offerings, Merger Agreements, New Preclinical Data, New Treatments and Dividend Payments - Research Report on XOMA, MAKO, Alnylam, Avanir, and PDL BioPharma 8:00 a.m. Dec. 18, 2013 - PR Newswire
Opening Buzz: Adobe Systems Incorporated, Restoration Hardware Holdings, XOMA Corp, Bed Bath & Beyond 9:16 a.m. Dec. 13, 2013 - ACCESSWIRE
XOMA Announces Pricing of Approximately $50.0 Million Offering of Common Stock 9:14 a.m. Dec. 13, 2013 - GlobeNewswire
XOMA Announces Proposed Public Offering of Common Stock 4:05 p.m. Dec. 12, 2013 - GlobeNewswire
Divestitures, Event Participations, Patents, Clinical Studies and Trials - Research Report on Allergan, Zoetis, XOMA, Isis, and Arrowhead 8:00 a.m. Dec. 5, 2013 - PR Newswire
Bullish Trend Analysis Report: Petroleo Brasileiro Petrobras, XOMA Corp, Groupon Inc, EnteroMedics Inc, Schlumberger Limited 8:45 a.m. Dec. 4, 2013 - PR Newswire
Bullish Trend Analysis: Tesla Motors Inc, XOMA Corp, Keryx Biopharmaceuticals, Oncomed Pharmaceuticals 9:01 a.m. Dec. 3, 2013 - ACCESSWIRE
XOMA to Present at the Piper Jaffray Healthcare Conference 1:00 p.m. Nov. 26, 2013 - GlobeNewswire
Under AAAResearchReports.com Microscope: Celldex Therapeutics Inc., XOMA Corp., Illumina Inc., and Immunomedics Inc. 9:30 a.m. Nov. 25, 2013 - PR Newswire
XOMA Awarded Key Flexible Manufacturing Patent 9:00 a.m. Nov. 20, 2013 - GlobeNewswire
Healthcare Sector Announced Financial Results and Recognition - Research Report on Alnylam Pharmaceuticals, Opko, Enzymotec, Cambrex, and XOMA 8:00 a.m. Nov. 15, 2013 - PR Newswire
XOMA Highlights Recent Achievements and Reports Financial Results for Third Quarter 2013 4:02 p.m. Nov. 7, 2013 - GlobeNewswire
(0)
(0)